LEAP-012 TRIAL IN PROGRESS: PEMBROLIZUMAB, LENVATINIB, AND TRANSARTERIAL CHEMOEMBOLIZATION COMBINATION THERAPY FOR INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA NOT AMENABLE TO CURATIVE TREATMENT

被引：0
|
作者：
Vogel, Arndt [1 ]
Llovet, Josep M. [2 ]
El-Khoueiry, Anthony B. [3 ]
Madoff, David C. [4 ,5 ]
Finn, Richard [6 ]
Ogasawara, Sadahisa [7 ]
Ren, Zhenggang [8 ]
Mody, Kalgi [9 ]
Li, Jerry J. [10 ]
Siegel, Abby B. [10 ]
Dubrovsky, Leonid [10 ]
Kudo, Masatoshi [11 ]
机构：
[1] Hannover Med Sch, Hannover, Germany
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA
[4] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
[5] Yale New Haven Hlth, Smilow Canc Hosp, New Haven, CT USA
[6] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[7] Chiba Univ, Grad Sch Med, Chiba, Japan
[8] Fudan Univ, Zhongshan Hosp, Dept Hepat Oncol, Shanghai, Peoples R China
[9] Eisai Inc, Woodcliff Lake, NJ USA
[10] Merck & Co Inc, Kenilworth, NJ USA
[11] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Higashiosaka, Osaka, Japan
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1156
引用
收藏
页码：697A / 698A
页数：2
相关论文
共 50 条
  • [31] Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study
    Lu, Linbin
    Zheng, Peichan
    Wu, Zhixian
    Chen, Xiong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma
    Endo, Kei
    Kuroda, Hidekatsu
    Oikawa, Takayoshi
    Okada, Yohei
    Fujiwara, Yudai
    Abe, Tamami
    Sato, Hiroki
    Sawara, Kei
    Takikawa, Yasuhiro
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (12) : 1575 - 1583
  • [33] Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
    Ando, Yuwa
    Kawaoka, Tomokazu
    Amioka, Kei
    Naruto, Kensuke
    Ogawa, Yutaro
    Yoshikawa, Yuki
    Kikukawa, Chihiro
    Kosaka, Yumi
    Uchikawa, Shinsuke
    Morio, Kei
    Fujino, Hatsue
    Nakahara, Takashi
    Murakami, Eisuke
    Yamauchi, Masami
    Tsuge, Masataka
    Hiramatsu, Akira
    Fukuhara, Takayuki
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Nonaka, Michihiro
    Hyogo, Hideyuki
    Aisaka, Yasuyuki
    Masaki, Keiichi
    Honda, Yoji
    Moriya, Takashi
    Naeshiro, Noriaki
    Takahashi, Shoichi
    Imamura, Michio
    Chayama, Kazuaki
    Aikata, Hiroshi
    ONCOLOGY, 2021, 99 (08) : 507 - 517
  • [34] Correction to: A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial Protocol
    Nicholas Fidelman
    CardioVascular and Interventional Radiology, 2022, 45 : 719 - 719
  • [35] Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma
    Pecorelli, Anna
    Lenzi, Barbara
    Gramenzi, Annagiulia
    Garuti, Francesca
    Farinati, Fabio
    Giannini, Edoardo G.
    Ciccarese, Francesca
    Piscaglia, Fabio
    Rapaccini, Gian Lodovico
    Di Marco, Maria
    Caturelli, Eugenio
    Zoli, Marco
    Borzio, Franco
    Sacco, Rodolfo
    Cabibbo, Giuseppe
    Felder, Martina
    Morisco, Filomena
    Gasbarrini, Antonio
    Baroni, Gianluca Svegliati
    Foschi, Francesco G.
    Biasini, Elisabetta
    Masotto, Alberto
    Virdone, Roberto
    Bernardi, Mauro
    Trevisani, Franco
    LIVER INTERNATIONAL, 2017, 37 (03) : 423 - 433
  • [36] Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning
    Peng, Jie
    Huang, Jinhua
    Huang, Guijia
    Zhang, Jing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma
    Lei Chen
    Xuefeng Kan
    Tao Sun
    Yanqiao Ren
    Yanyan Cao
    Liangliang Yan
    Bin Liang
    Bin Xiong
    Chuansheng Zheng
    BMC Gastroenterology, 20
  • [38] Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma
    Chen, Lei
    Kan, Xuefeng
    Sun, Tao
    Ren, Yanqiao
    Cao, Yanyan
    Yan, Liangliang
    Liang, Bin
    Xiong, Bin
    Zheng, Chuansheng
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [39] Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases
    Izumoto, Hirofumi
    Hiraoka, Atsushi
    Ishimaru, Yoshihiro
    Murakami, Tadashi
    Kitahata, Shogo
    Ueki, Hidetaro
    Aibiki, Toshihiko
    Okudaira, Tomonari
    Miyamoto, Yuji
    Yamago, Hiroka
    Iwasaki, Ryuichiro
    Tomida, Hideomi
    Mori, Kenichiro
    Kishida, Masato
    Tsubouchi, Eiji
    Miyata, Hideki
    Ninomiya, Tomoyuki
    Kawasaki, Hideki
    Hirooka, Masashi
    Matsuura, Bunzo
    Abe, Masanori
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    ONCOLOGY, 2017, 93 : 120 - 126
  • [40] Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies
    Kariyama, Kazuya
    Nouso, Kazuhiro
    Wakuta, Akiko
    Oonishi, Ayano
    Toyoda, Hidenori
    Tada, Toshifumi
    Hiraoka, Atsushi
    Tsuji, Kunihiko
    Itobayashi, Ei
    Ishikawa, Toru
    Takaguchi, Koichi
    Tsutsui, Akemi
    Shimada, Noritomo
    Kumada, Takashi
    LIVER CANCER, 2020, 9 (01) : 41 - 49
12345